cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Design Therapeautics Inc
3 own
2 watching
Current Price
$8.2
$0.23
(2.89%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
457.89M
52-Week High
52-Week High
26.3
52-Week Low
52-Week Low
6.9425
Average Volume
Average Volume
0.32M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization457.89M
icon52-Week High26.3
icon52-Week Low6.9425
iconAverage Volume0.32M
iconDividend Yield--
iconP/E Ratio--
What does the Design Therapeautics Inc do?
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company s portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction; and Myotonic Dystrophy Type-1 (DM1), a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs. It is also developing GeneTAC product candidate portfolio for the treatment of other nucleotide repeat expansion-driven monogenic diseases, such as Fragile X syndrome, spinocerebellar ataxias, amyotrophic lateral sclerosis, frontotemporal dementia, Huntington disease, and spinobulbar muscular atrophy. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.
Read More
How much money does Design Therapeautics Inc make?
News & Events about Design Therapeautics Inc.
PR Newswire
30days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Design Therapeutics, Inc. - DSGN PR Newswire NEW YORK, Jan. 4, 2023 NEW YORK, Jan. 4, 2023...
Globe Newswire
1month ago
NEW YORK, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Design Therapeutics, Inc. (Design or the Company) (NASDAQ: DSGN) on behalf of Design stockholders. Our investigation concerns ...
Globe Newswire
1month ago
NEW YORK, Dec. 24, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Design Therapeutics, Inc. (Design or the Company) (NASDAQ:DSGN). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The ...
Ticker Report
1month ago
Design Therapeutics, Inc. (NASDAQ:DSGN Get Rating) Director Simeon George purchased 360,000 shares of the stock in a transaction dated Monday, December 19th. The stock was acquired at an average cost of $8.63 per share, for a total transaction of $3,106,800.00. Following the completion of ...
Ticker Report
1month ago
Design Therapeutics, Inc. (NASDAQ:DSGN Get Rating) Director Simeon George acquired 500,000 shares of the businesss stock in a transaction dated Friday, December 16th. The shares were bought at an average price of $8.28 per share, for a total transaction of $4,140,000.00. Following the...
Frequently Asked Questions
Frequently Asked Questions
What is Design Therapeautics Inc share price today?
plus_minus_icon
Can Indians buy Design Therapeautics Inc shares?
plus_minus_icon
How can I buy Design Therapeautics Inc shares from India?
plus_minus_icon
Can Fractional shares of Design Therapeautics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Design Therapeautics Inc stocks?
plus_minus_icon
What is today’s traded volume of Design Therapeautics Inc?
plus_minus_icon
What is today’s market capitalisation of Design Therapeautics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Design Therapeautics Inc?
plus_minus_icon
What percentage is Design Therapeautics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Design Therapeautics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$8.2
$0.23
(2.89%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00